Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (241-250 of 1,622) with videos related to

Pageof 163
Sort By:
The Western Journal of Medicine|August 1, 1985
Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinomaM Markman
F1000 Medicine Reports|October 16, 2010
Update on the utility of prognostic biomarkers in ovarian cancerMaurie Markman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Surgical intervention in relapsed ovarian cancer is beneficial: contraM Markman
Dental Economics - Oral Hygiene|August 1, 1978
Broken appointmentsS Markman
The Western Journal of Medicine|March 1, 1985
Intracavitary chemotherapy for malignant disease confined to body cavitiesM Markman
Oncology (Williston Park, N.Y.)|March 17, 2017
Maurie Markman on the Groundbreaking TAPUR TrialMaurie Markman
Oncology|August 8, 2019
Lenvatinib Real-Life ExperienceMaurie Markman
The Oncologist|February 3, 2004
Ethical conflict in providing informed consent for clinical trials: a problematic example from the gynecologic cancer research communityMaurie Markman
Cleveland Clinic Journal of Medicine|January 27, 2004
Genetic discrimination arising from cancer risk assessments: a societal dilemmaMaurie Markman
Current Oncology Reports|May 27, 2004
Translating the results of phase III randomized cancer trials into the language of physician obligation to patientsMaurie Markman
Pageof 163

Showing results (241-250 of 1,622) with videos related to

Sort By:
Pageof 163
The Western Journal of Medicine|August 1, 1985
Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinomaM Markman
F1000 Medicine Reports|October 16, 2010
Update on the utility of prognostic biomarkers in ovarian cancerMaurie Markman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Surgical intervention in relapsed ovarian cancer is beneficial: contraM Markman
Dental Economics - Oral Hygiene|August 1, 1978
Broken appointmentsS Markman
The Western Journal of Medicine|March 1, 1985
Intracavitary chemotherapy for malignant disease confined to body cavitiesM Markman
Oncology (Williston Park, N.Y.)|March 17, 2017
Maurie Markman on the Groundbreaking TAPUR TrialMaurie Markman
Oncology|August 8, 2019
Lenvatinib Real-Life ExperienceMaurie Markman
The Oncologist|February 3, 2004
Ethical conflict in providing informed consent for clinical trials: a problematic example from the gynecologic cancer research communityMaurie Markman
Cleveland Clinic Journal of Medicine|January 27, 2004
Genetic discrimination arising from cancer risk assessments: a societal dilemmaMaurie Markman
Current Oncology Reports|May 27, 2004
Translating the results of phase III randomized cancer trials into the language of physician obligation to patientsMaurie Markman
Pageof 163